Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Journal Watch

    • 12 Accesses

    This is a preview of subscription content, log in to check access.

    References

    1. Stoch SA, Wagner JA. Biomarker analysis as a decision-making tool in drug discovery and development: implications for peroxisome proliferator-activator receptors. Int J Pharm Med 2007; 21(4): 271–7

    Reference

    1. Cantini F, Niccoli L, Nannini C, et al. Diagnosis and treatment of giant cell arteritis. Drugs Aging 2008; 25(4): 281–97

    Reference

    1. Czaia AJ. Clinical features, differential diagnosis and treatment of autoimmune hepatitis in the elderly. Drugs Aging 2008; 25(3): 219–39

    Reference

    1. Kato T. Mitochondrial dysfunction as the molecular basis of bipolar disorder: therapeutic implications. CNS Drugs 2007; 21(1): 1–11

    Reference

    1. Klotz U. The role of pharmacogenetics in the metabolism of antiepileptic drugs: pharmacokinetic and therapeutic implications. Clin Pharmacokinet 2007; 46(4): 271–9

    Reference

    1. Stowasser M, Fallo F, So A, et al. Genetic forms of primary aldosteronism. High Blood Press Cardiovasc Prevention 2007; 14(2): 75–81

    Reference

    1. Pucci MJ. Novel genetic techniques and approaches in the microbial genomics era: identification and/or validation of targets for the discovery of new antibacterial agents. Drugs RD 2007; 8(4): 201–12

    Reference

    1. Press MF, Lenz, H-J. EGFR, HER2 and VEGF pathways: validated targets for cancer treatment. Drugs 2007; 67(14): 2045–75

    Reference

    1. Apostolidou E, Swords R, Alvarado Y, et al. Treatment of acute lymphoblastic leukaemia: a new era. Drugs 2007; 67(15): 2153–71

    Reference

    1. Kontzias A, Efthimiou P. Adult-onset Still’s disease: pathogenesis, clinical manifestations and therapeutic advances. Drugs 2008; 68(3): 319–37

    Reference

    1. Norata GD, Catapano AL. Molecular mechanisms responsible for the anti-inflammatory and protective effect of high-density lipoprotein on the endothelium. High Blood Press Cardiovasc Prevention 2007; 14(1): 21–31

    Reference

    1. Colombo L, Margaglione M, Colombo M, et al. Genetic polymorphisms in an aged population: comparisons with a large population of subjects and with young survivors of myocardial infarction. High Blood Press Cardiovasc Prevention 2007; 14(2): 99–101

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Journal Watch. Mol Diag Ther 12, 125–129 (2008). https://doi.org/10.1007/BF03256277

    Download citation